# A Study to Evaluate the Efficacy and Safety of ALH-L1005 in Patients With Chronic Periodontitis

> **NCT04503746** · PHASE2 · COMPLETED · sponsor: **AngioLab, Inc.** · enrollment: 117 (actual)

## Conditions studied

- Chronic Periodontitis

## Interventions

- **DRUG:** ALH-L1005 600mg/day
- **DRUG:** ALH-L1005 1,200mg/day
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04503746
- **Lead sponsor:** AngioLab, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-16
- **Primary completion:** 2021-12-13
- **Final completion:** 2021-12-13
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2022-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04503746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04503746, "A Study to Evaluate the Efficacy and Safety of ALH-L1005 in Patients With Chronic Periodontitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04503746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*